Correlation Between Avidity Biosciences and Tcr2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Avidity Biosciences and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avidity Biosciences and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avidity Biosciences and Tcr2 Therapeutics, you can compare the effects of market volatilities on Avidity Biosciences and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avidity Biosciences with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avidity Biosciences and Tcr2 Therapeutics.
Diversification Opportunities for Avidity Biosciences and Tcr2 Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Avidity and Tcr2 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Avidity Biosciences and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Avidity Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avidity Biosciences are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Avidity Biosciences i.e., Avidity Biosciences and Tcr2 Therapeutics go up and down completely randomly.
Pair Corralation between Avidity Biosciences and Tcr2 Therapeutics
If you would invest 2,918 in Avidity Biosciences on December 28, 2024 and sell it today you would earn a total of 263.00 from holding Avidity Biosciences or generate 9.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Avidity Biosciences vs. Tcr2 Therapeutics
Performance |
Timeline |
Avidity Biosciences |
Tcr2 Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Avidity Biosciences and Tcr2 Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Avidity Biosciences and Tcr2 Therapeutics
The main advantage of trading using opposite Avidity Biosciences and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avidity Biosciences position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.Avidity Biosciences vs. Revolution Medicines | Avidity Biosciences vs. Black Diamond Therapeutics | Avidity Biosciences vs. Passage Bio | Avidity Biosciences vs. Akero Therapeutics |
Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc | Tcr2 Therapeutics vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |